Zika Vaccines Market 2022-2028: Industry Analysis, Trends, Growth, Opportunities, and Forecast

The Zika Vaccines Market size is expected to grow at an annual average of 5% during 2022-2028. Zika virus (ZIKV), also known as flavivirus in the Flavivirus family, is a mosquito-borne disease transmitted from an infected pregnant woman to her baby through mosquitoes, blood transfusions, and sexual intercourse. When a mosquito bites a person infected with the Zika virus, it infects the virus and transmits it to the stinger. Zika virus infection can cause neurological abnormalities and birth defects in the fetus. The Zika vaccine is designed to help people prevent and manage diseases caused by the Zika virus.

The following segmentation are covered in this report:

By Application

• Therapeutic
• Preventive

By End User

• Hospitals
• Clinics
• Research Centers
• Others

Company Profile

• GeneOne Life Science, Inc.
• Inovio Pharmaceuticals, Inc.
• Takeda Pharmaceutical Co. Ltd.
• Immunovaccine, Inc.
• Emergent BioSolutions, Inc.
• Moderna, Inc.
• Themis Bioscience GmbH
• Others

Scope of the report

The research study analyses the Zika Vaccines Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Zika Vaccines Market Report

• What was the Zika Vaccines Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Zika Vaccines Market was the market leader in 2022?